Organized and delivered in collaboration with the Dutch Medicines Evaluation Board (MEB), this face-to-face training course covers the major pharmacovigilance processes as outlined in GVP I to XVI. It is designed to provide a strong foundation in all key aspects of European Post-Marketing Safety regulatory requirements.
Furthermore, it includes highlights and updates on the pharmacovigilance legislation as well as the latest news on the ICH activities in pharmacovigilance.
This training course will take place in Amsterdam, allowing live interaction and real-time Q&A with the large panel of renowned experts onsite. We have also decided to make this course available for virtual participation, with some limitation regarding interaction with fellow participants and faculty members. You can register for your preferred format immediately and without concern: DIA will monitor the situation and keep all registrants informed on a regular basis.
Benefit from a discount!
Are you a member of the Swiss Biotech Association?
Get a 15% discount on the registration fee.
If you wish to register with the discount, download and complete the Registration Form. Please send a scanned copy of the Registration Form with SBA membership confirmation via email to Basel@DIAglobal.org.
Are you a professional from a Small and Medium-Sized Enterprise (SME)?
A 35% discount is available to professionals from small and medium-sized enterprises (SMEs) which are registered as SMEs. To benefit from the discounted rate the company needs to be listed on the EMA SME site or alternatively we require an SME registration confirmation document with the validity date included.
If you wish to register with the SME discount, download and complete the Registration Form. Please send a scanned copy of the Registration Form with your company's SME number included via email to Basel@DIAglobal.org.